Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization Article Swipe
Daniel R. Feikin
,
Melissa M. Higdon
,
Nick Andrews
,
Shirley Collie
,
Maria Deloria Knoll
,
Jeffrey C. Kwong
,
Ruth Link‐Gelles
,
Tamara Pilishvili
,
Minal Patel
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.vaccine.2023.02.020
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.vaccine.2023.02.020
Related Topics
Concepts
Coronavirus disease 2019 (COVID-19)
Medicine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Disease
Infectious disease (medical specialty)
Internal medicine
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.vaccine.2023.02.020
- OA Status
- green
- Cited By
- 35
- References
- 44
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4319726710
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4319726710Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.vaccine.2023.02.020Digital Object Identifier
- Title
-
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health OrganizationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-02-09Full publication date if available
- Authors
-
Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll, Jeffrey C. Kwong, Ruth Link‐Gelles, Tamara Pilishvili, Minal PatelList of authors in order
- Landing page
-
https://doi.org/10.1016/j.vaccine.2023.02.020Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/9910025Direct OA link when available
- Concepts
-
Coronavirus disease 2019 (COVID-19), Medicine, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Virology, Disease, Infectious disease (medical specialty), Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
35Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 9, 2024: 13, 2023: 12, 2022: 1Per-year citation counts (last 5 years)
- References (count)
-
44Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4319726710 |
|---|---|
| doi | https://doi.org/10.1016/j.vaccine.2023.02.020 |
| ids.doi | https://doi.org/10.1016/j.vaccine.2023.02.020 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36797097 |
| ids.openalex | https://openalex.org/W4319726710 |
| fwci | 9.57693838 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000517 |
| mesh[1].descriptor_ui | D000086382 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | prevention & control |
| mesh[1].descriptor_name | COVID-19 |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000086663 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | COVID-19 Vaccines |
| mesh[3].qualifier_ui | Q000235 |
| mesh[3].descriptor_ui | D000086402 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | genetics |
| mesh[3].descriptor_name | SARS-CoV-2 |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D000087507 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Vaccine Efficacy |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D014944 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | World Health Organization |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D006801 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Humans |
| mesh[7].qualifier_ui | Q000517 |
| mesh[7].descriptor_ui | D000086382 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | prevention & control |
| mesh[7].descriptor_name | COVID-19 |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000086663 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | COVID-19 Vaccines |
| mesh[9].qualifier_ui | Q000235 |
| mesh[9].descriptor_ui | D000086402 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | genetics |
| mesh[9].descriptor_name | SARS-CoV-2 |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000087507 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Vaccine Efficacy |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D014944 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | World Health Organization |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | Q000517 |
| mesh[13].descriptor_ui | D000086382 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | prevention & control |
| mesh[13].descriptor_name | COVID-19 |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000086663 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | COVID-19 Vaccines |
| mesh[15].qualifier_ui | Q000235 |
| mesh[15].descriptor_ui | D000086402 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | genetics |
| mesh[15].descriptor_name | SARS-CoV-2 |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000087507 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Vaccine Efficacy |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D014944 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | World Health Organization |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | Q000517 |
| mesh[19].descriptor_ui | D000086382 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | prevention & control |
| mesh[19].descriptor_name | COVID-19 |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000086663 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | COVID-19 Vaccines |
| mesh[21].qualifier_ui | Q000235 |
| mesh[21].descriptor_ui | D000086402 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | genetics |
| mesh[21].descriptor_name | SARS-CoV-2 |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000087507 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Vaccine Efficacy |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D014944 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | World Health Organization |
| type | article |
| title | Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization |
| biblio.issue | 14 |
| biblio.volume | 41 |
| biblio.last_page | 2338 |
| biblio.first_page | 2329 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9930999875068665 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T11754 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9873999953269958 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | SARS-CoV-2 detection and testing |
| is_xpac | False |
| apc_list.value | 3500 |
| apc_list.currency | USD |
| apc_list.value_usd | 3500 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3008058167 |
| concepts[0].level | 4 |
| concepts[0].score | 0.48063555359840393 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[0].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.45476725697517395 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C3007834351 |
| concepts[2].level | 5 |
| concepts[2].score | 0.4279840588569641 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[3].id | https://openalex.org/C159047783 |
| concepts[3].level | 1 |
| concepts[3].score | 0.40969908237457275 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[3].display_name | Virology |
| concepts[4].id | https://openalex.org/C2779134260 |
| concepts[4].level | 2 |
| concepts[4].score | 0.3623846173286438 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[4].display_name | Disease |
| concepts[5].id | https://openalex.org/C524204448 |
| concepts[5].level | 3 |
| concepts[5].score | 0.15853533148765564 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[5].display_name | Infectious disease (medical specialty) |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.1532573699951172 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[0].score | 0.48063555359840393 |
| keywords[0].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.45476725697517395 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[2].score | 0.4279840588569641 |
| keywords[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[3].id | https://openalex.org/keywords/virology |
| keywords[3].score | 0.40969908237457275 |
| keywords[3].display_name | Virology |
| keywords[4].id | https://openalex.org/keywords/disease |
| keywords[4].score | 0.3623846173286438 |
| keywords[4].display_name | Disease |
| keywords[5].id | https://openalex.org/keywords/infectious-disease |
| keywords[5].score | 0.15853533148765564 |
| keywords[5].display_name | Infectious disease (medical specialty) |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.1532573699951172 |
| keywords[6].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1016/j.vaccine.2023.02.020 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S27359860 |
| locations[0].source.issn | 0264-410X, 1873-2518 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0264-410X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Vaccine |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Vaccine |
| locations[0].landing_page_url | https://doi.org/10.1016/j.vaccine.2023.02.020 |
| locations[1].id | pmid:36797097 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Vaccine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36797097 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:9910025 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Vaccine |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9910025 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5106707981 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5154-5084 |
| authorships[0].author.display_name | Daniel R. Feikin |
| authorships[0].countries | CH |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland |
| authorships[0].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[0].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[0].institutions[0].country_code | CH |
| authorships[0].institutions[0].display_name | World Health Organization |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Daniel R. Feikin |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland |
| authorships[1].author.id | https://openalex.org/A5017551968 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1932-9442 |
| authorships[1].author.display_name | Melissa M. Higdon |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[1].affiliations[0].raw_affiliation_string | International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA |
| authorships[1].institutions[0].id | https://openalex.org/I145311948 |
| authorships[1].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Johns Hopkins University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Melissa M. Higdon |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA |
| authorships[2].author.id | https://openalex.org/A5072485453 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2069-2684 |
| authorships[2].author.display_name | Nick Andrews |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4387153084 |
| authorships[2].affiliations[0].raw_affiliation_string | UK Health Security Agency, London, United Kingdom |
| authorships[2].institutions[0].id | https://openalex.org/I4387153084 |
| authorships[2].institutions[0].ror | https://ror.org/018h10037 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1311074006, https://openalex.org/I4387153084 |
| authorships[2].institutions[0].country_code | |
| authorships[2].institutions[0].display_name | UK Health Security Agency |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nick Andrews |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | UK Health Security Agency, London, United Kingdom |
| authorships[3].author.id | https://openalex.org/A5090247671 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4300-9649 |
| authorships[3].author.display_name | Shirley Collie |
| authorships[3].affiliations[0].raw_affiliation_string | Discovery Health, Johannesburg, South Africa |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Shirley Collie |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Discovery Health, Johannesburg, South Africa |
| authorships[4].author.id | https://openalex.org/A5020562642 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9041-2671 |
| authorships[4].author.display_name | Maria Deloria Knoll |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[4].affiliations[0].raw_affiliation_string | International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA |
| authorships[4].institutions[0].id | https://openalex.org/I145311948 |
| authorships[4].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Johns Hopkins University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Maria Deloria Knoll |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA |
| authorships[5].author.id | https://openalex.org/A5078064190 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7820-2046 |
| authorships[5].author.display_name | Jeffrey C. Kwong |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210125326 |
| authorships[5].affiliations[0].raw_affiliation_string | ICES and Public Health Ontario, Toronto, Ontario, Canada |
| authorships[5].institutions[0].id | https://openalex.org/I4210125326 |
| authorships[5].institutions[0].ror | https://ror.org/025z8ah66 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210125326 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Public Health Ontario |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jeffrey C. Kwong |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | ICES and Public Health Ontario, Toronto, Ontario, Canada |
| authorships[6].author.id | https://openalex.org/A5020614173 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9617-806X |
| authorships[6].author.display_name | Ruth Link‐Gelles |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I19085752 |
| authorships[6].affiliations[0].raw_affiliation_string | National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA |
| authorships[6].affiliations[1].raw_affiliation_string | U.S. Public Health Service Commissioned Corps, Rockville, MD, USA |
| authorships[6].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[6].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[6].institutions[1].id | https://openalex.org/I19085752 |
| authorships[6].institutions[1].ror | https://ror.org/05je2tx78 |
| authorships[6].institutions[1].type | facility |
| authorships[6].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ruth Link-Gelles |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA, U.S. Public Health Service Commissioned Corps, Rockville, MD, USA |
| authorships[7].author.id | https://openalex.org/A5064280673 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Tamara Pilishvili |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I19085752 |
| authorships[7].affiliations[0].raw_affiliation_string | National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA |
| authorships[7].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[7].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[7].institutions[1].id | https://openalex.org/I19085752 |
| authorships[7].institutions[1].ror | https://ror.org/05je2tx78 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tamara Pilishvili |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA |
| authorships[8].author.id | https://openalex.org/A5101999368 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8707-7531 |
| authorships[8].author.display_name | Minal Patel |
| authorships[8].countries | CH |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland |
| authorships[8].affiliations[1].raw_affiliation_string | U.S. Public Health Service Commissioned Corps, Rockville, MD, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[8].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[8].institutions[0].country_code | CH |
| authorships[8].institutions[0].display_name | World Health Organization |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Minal K. Patel |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland, U.S. Public Health Service Commissioned Corps, Rockville, MD, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9910025 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W4206669628, https://openalex.org/W4224279380, https://openalex.org/W4205317059, https://openalex.org/W3176864053, https://openalex.org/W3198183218, https://openalex.org/W4206651655, https://openalex.org/W4206548596, https://openalex.org/W4292098121, https://openalex.org/W4210433452, https://openalex.org/W3036314732 |
| cited_by_count | 35 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 9 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 13 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 12 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:9910025 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Vaccine |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9910025 |
| primary_location.id | doi:10.1016/j.vaccine.2023.02.020 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S27359860 |
| primary_location.source.issn | 0264-410X, 1873-2518 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0264-410X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Vaccine |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Vaccine |
| primary_location.landing_page_url | https://doi.org/10.1016/j.vaccine.2023.02.020 |
| publication_date | 2023-02-09 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4224287290, https://openalex.org/W4200175757, https://openalex.org/W4296686923, https://openalex.org/W4200320470, https://openalex.org/W4283326436, https://openalex.org/W4281710411, https://openalex.org/W4283704819, https://openalex.org/W4309188721, https://openalex.org/W6806207965, https://openalex.org/W4200192318, https://openalex.org/W4309473723, https://openalex.org/W4306969029, https://openalex.org/W4284991356, https://openalex.org/W6847403748, https://openalex.org/W4295761788, https://openalex.org/W4281489105, https://openalex.org/W6847340395, https://openalex.org/W4302283217, https://openalex.org/W4285590921, https://openalex.org/W4307858408, https://openalex.org/W4281827985, https://openalex.org/W4306942168, https://openalex.org/W4307399948, https://openalex.org/W4315779712, https://openalex.org/W4220739924, https://openalex.org/W3163785571, https://openalex.org/W4282917839, https://openalex.org/W4225285640, https://openalex.org/W2990987718, https://openalex.org/W4289824658, https://openalex.org/W4289794014, https://openalex.org/W4298145582, https://openalex.org/W4310718488, https://openalex.org/W4311359167, https://openalex.org/W4324303557, https://openalex.org/W4312109325, https://openalex.org/W4206790844, https://openalex.org/W4293113133, https://openalex.org/W4225729728, https://openalex.org/W4226246286, https://openalex.org/W4323534146, https://openalex.org/W4308922128, https://openalex.org/W4225942701, https://openalex.org/W4303473644 |
| referenced_works_count | 44 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5106707981 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 9 |
| corresponding_institution_ids | https://openalex.org/I4210105654 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7300000190734863 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98122691 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |